Original paper

Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model

Volume: 12, Issue: 1
Published: Mar 19, 2021
Abstract
Despite no or limited pre-clinical evidence, repurposed drugs are massively evaluated in clinical trials to palliate the lack of antiviral molecules against SARS-CoV-2. Here we use a Syrian hamster model to assess the antiviral efficacy of favipiravir, understand its mechanism of action and determine its pharmacokinetics. When treatment is initiated before or simultaneously to infection, favipiravir has a strong dose effect, leading to reduction...
Paper Details
Title
Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model
Published Date
Mar 19, 2021
Volume
12
Issue
1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.